[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334696-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334696-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","squalene-epoxidase-its-regulations-and-links-with-cancers","Squalene Epoxidase: Its Regulations and Links with Cancers","","Squalene epoxidase (SQLE) is a key enzyme in the mevalonate–cholesterol pathway, catalyzing the conversion of squalene to 2,3-epoxysqualene and initiating the first oxygenation step. The review synthesizes recent functional and mechanistic findings describing how SQLE contributes to cancer biology, including its value as a diagnostic and prognostic marker. It highlights multi-level regulation of SQLE and its involvement in the crosstalk with iron-dependent cell death, then summarizes research across different cancers and the therapeutic potential of SQLE inhibitors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/squalene-epoxidase-its-regulations-and-links-with-cancers/334696/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/squalene-epoxidase-its-regulations-and-links-with-cancers/334696.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does SQLE play in the mevalonate–cholesterol pathway?","Question",{"text":63,"@type":64},"SQLE converts squalene to 2,3-epoxysqualene and catalyzes the first oxygenation step of the pathway. This places SQLE as a rate-limiting enzyme in cholesterol synthesis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is cholesterol connected to cancer progression?",{"text":68,"@type":64},"Accumulation of cholesterol in malignant tumors is described as a well-known phenomenon. Cholesterol and LDL expression are reported as risk factors associated with worse prognoses in several cancer types.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic approaches are discussed regarding SQLE?",{"text":72,"@type":64},"The review discusses therapeutic implications of SQLE inhibitors and summarizes their potential clinical values. It frames these inhibitors as tools targeting SQLE-related mechanisms in cancers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334696,1790211555,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Review  \nSqualene Epoxidase: Its Regulations and Links with Cancers  \nLin Zhang 1,†, Zheng Cao 2,†, Yuheng Hong 3, Haihua He 3,4, Leifeng Chen 3,4, Zhentao Yu 1,* and Yibo Gao 5,6,7, *  \nCitation: Zhang, L.; Cao, Z.; Hong, Y.; He, H.; Chen, L.; Yu, Z.; Gao, Y. Squalene Epoxidase: Its Regulations and Links with Cancers. Int. J. Mol.  \nSci. 2024, 25, 3874. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25073874](10.3390/ijms25073874)  \nAcademic Editor: Mauro Coluccia  \nReceived: 9 January 2024  \nRevised: 9 March 2024  \nAccepted: 19 March 2024  \nPublished: 30 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China  \n2 Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China  \n3 Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China  \n4 Department of Oncology, Renmin Hospital of Wuhan University, Wuhan 430060, China  \n5 Central Laboratory & Shenzhen Key Laboratory of Epigenetics and Precision Medicine for Cancers, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China  \n6 State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China  \n7 Laboratory of Translational Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China  \n* [Correspondence: yuzhentao@chcamssz.ac.cn](Correspondence: yuzhentao@chcamssz.ac.cn) (Z.Y.); [gaoyibo@cicams.ac.cn](gaoyibo@cicams.ac.cn) (Y.G.);  \nTel.: +86-0755-6661-8168 (Z.Y.); +86-010-67781331 (Y.G.)† These authors contributed equally to this work.  \nAbstract: Squalene epoxidase (SQLE) is a key enzyme in the mevalonate–cholesterol pathway that plays a critical role in cellular physiological processes. It converts squalene to 2,3-epoxysqualene and catalyzes the first oxygenation step in the pathway. Recently, intensive efforts have been made to extend the current knowledge of SQLE in cancers through functional and mechanistic studies. However, the underlying mechanisms and the role of SQLE in cancers have not been fully elucidated yet. In this review, we retrospected current knowledge of SQLE as a rate-limiting enzyme in themevalonate–cholesterol pathway, while shedding light on its potential as a diagnostic and prognostic marker, and revealed its therapeutic values in cancers. We showed that SQLE is regulated at different levels and is involved in the crosstalk with iron-dependent cell death. Particularly, we systemically reviewed the research findings on the role of SQLE in different cancers. Finally, we discussed the therapeutic implications of SQLE inhibitors and summarized their potential clinical values. Overall, this review discussed the multifaceted mechanisms that involve SQLE to present a vivid panorama of SQLE in cancers.  \nKeywords: SQLE; mevalonate pathway; cholesterol metabolism; ferroptosis; cancer  \n1. Backgroun","cbCaim7FuNPNEAYF","https://ap.wps.com/l/cbCaim7FuNPNEAYF","pdf",3934106,28,"English","# Background\n## Cholesterol as a driver in tumor growth\n## Cellular sources and synthesis of cholesterol\n## SQLE as a rate-limiting enzyme in the mevalonate–cholesterol pathway\n# Cancer relevance of SQLE\n## Regulation of SQLE and mechanistic roles\n## SQLE links with iron-dependent cell death\n# Therapeutic implications\n## SQLE inhibitors and clinical value","[{\"question\":\"What role does SQLE play in the mevalonate–cholesterol pathway?\",\"answer\":\"SQLE converts squalene to 2,3-epoxysqualene and catalyzes the first oxygenation step of the pathway. This places SQLE as a rate-limiting enzyme in cholesterol synthesis.\"},{\"question\":\"How is cholesterol connected to cancer progression?\",\"answer\":\"Accumulation of cholesterol in malignant tumors is described as a well-known phenomenon. Cholesterol and LDL expression are reported as risk factors associated with worse prognoses in several cancer types.\"},{\"question\":\"What therapeutic approaches are discussed regarding SQLE?\",\"answer\":\"The review discusses therapeutic implications of SQLE inhibitors and summarizes their potential clinical values. It frames these inhibitors as tools targeting SQLE-related mechanisms in cancers.\"}]","Squalene Epoxidase: Its Regulations and Links with Cancers | PDF",1790007925,71]